Milestones Administradora de Recursos Ltda. Has $8.57 Million Position in Danaher Corporation $DHR

Key Points

• Milestones Administradora de Recursos Ltda. increased its position in Danaher Corporation by 363.9%, owning 43,370 shares valued at approximately $8.57 million after purchasing 34,020 shares in the second quarter.
• Wall Street analysts have positive forecasts for Danaher, with an average price target of $244.60 and a consensus rating of "Moderate Buy," demonstrating strong investor interest.
• Danaher recently announced a quarterly dividend of $0.32, marking an annualized yield of 0.6%, and has a current payout ratio of 27.23%.

Milestones Administradora de Recursos Ltda. raised its position in Danaher Corporation (NYSE:DHR - Free Report) by 363.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 43,370 shares of the conglomerate's stock after purchasing an additional 34,020 shares during the quarter. Danaher accounts for about 2.9% of Milestones Administradora de Recursos Ltda.'s holdings, making the stock its 9th biggest holding. Milestones Administradora de Recursos Ltda.'s holdings in Danaher were worth $8,567,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the business. Conning Inc. raised its holdings in Danaher by 10.2% in the 2nd quarter. Conning Inc. now owns 23,581 shares of the conglomerate's stock valued at $4,658,000 after buying an additional 2,181 shares during the last quarter. Eastern Bank raised its stake in shares of Danaher by 1.6% during the second quarter. Eastern Bank now owns 186,533 shares of the conglomerate's stock valued at $36,848,000 after acquiring an additional 2,958 shares during the last quarter. Aberdeen Group plc raised its stake in shares of Danaher by 4.7% during the second quarter. Aberdeen Group plc now owns 1,158,897 shares of the conglomerate's stock valued at $229,334,000 after acquiring an additional 52,124 shares during the last quarter. Lmcg Investments LLC raised its stake in shares of Danaher by 11.4% during the second quarter. Lmcg Investments LLC now owns 115,839 shares of the conglomerate's stock valued at $22,883,000 after acquiring an additional 11,851 shares during the last quarter. Finally, Blue Zone Wealth Advisors LLC raised its stake in shares of Danaher by 12.8% during the second quarter. Blue Zone Wealth Advisors LLC now owns 21,683 shares of the conglomerate's stock valued at $4,283,000 after acquiring an additional 2,462 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of several analyst reports. Royal Bank Of Canada set a $241.00 target price on Danaher in a research report on Tuesday, September 2nd. Robert W. Baird raised their price objective on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. UBS Group lowered their price objective on Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research report on Wednesday, July 23rd. Evercore ISI raised their price target on shares of Danaher from $226.00 to $245.00 and gave the stock an "outperform" rating in a report on Tuesday. Finally, Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a report on Friday, July 11th. Seventeen analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $244.60.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of the business's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 11.10% of the stock is owned by insiders.

Danaher Stock Down 1.0%

Danaher stock opened at $202.53 on Friday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.41. The firm's fifty day moving average is $200.66 and its 200 day moving average is $197.25. The company has a market capitalization of $145.02 billion, a PE ratio of 43.09, a PEG ratio of 2.91 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the company earned $1.72 EPS. Danaher's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's payout ratio is presently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.